Four major measures to prevent lung cancer recurrence

The recurrence of lung cancer is the most difficult situation in the treatment of cancer. To prevent the recurrence of lung cancer, it is important to pay attention to the following aspects:

1. Avoid mental stimulation, colds, infections and excessive fatigue

2. Strictly implement cancer-free surgery during the operation to avoid and eliminate iatrogenic implants.

Lobectomy should be performed for small unilobar lesions;

For interlobar lesions, multilobectomy should be performed if lung function permits, and lobectomy plus partial resection of the invaded adjacent lobe should be avoided;

Sleeve lobectomy should maximize the length of the bronchial resection margin to remove existing cancer cells as much as possible and reduce recurrence.

3. After the first radical treatment, immunotherapy and Chinese and Western medicine with systemic therapeutic effects are given to restore the body's immune function as soon as possible, eliminate residual cancer cells, or further strengthen the body and eliminate evil. Especially for those with positive resection ends confirmed by postoperative pathology, bronchofiberscope, sputum or other examinations should be performed regularly (3 to 6 months) and local radiotherapy should be performed as soon as possible. Chemotherapy has no obvious effect on reducing the mortality rate of recurrence at the original site or ipsilateral recurrence. Traditional Chinese medicine treatment and nonspecific immunotherapy can be used as important treatment methods. The multidisciplinary comprehensive treatment model is the development trend of active treatment of cancer patients today, and this principle should be followed even more for patients with positive resection ends.

4. While actively carrying out targeted prospective research, we should strictly control the indications for blood transfusion and encourage autologous blood transfusion or blood transfusion to reduce the impact of blood transfusion on the immune function of patients with non-cancer or other malignant tumors and reduce the risk of postoperative recurrence.